Visit the Chemometec web site
Click on the advert above to visit the company web site

Product category: Cell/tissue handling and counting
News Release from: Genetix | Subject: ClonePixFL
Edited by the Laboratorytalk Editorial Team on 07 February 2005

Breakthrough in development of
biopharmaceuticals

Cell imaging and picking instrument enables the selection of cells using quantitative measurements based on the pharmacological properties of affinity and specificity

Genetix has announced the launch of their next generation mammalian cell imaging and picking instrument, the ClonePixFL The ClonePixFL adds fluorescent capabilities to the ClonePix's ability to pick antibody producing clones

The device enables the selection of cells using quantitative measurements based on the pharmacological properties of affinity and specificity, the criteria that determine whether a drug will succeed or fail.

This approach is designed to dramatically reduce the time and cost of introducing biopharmaceutical products.

Large populations of cells can be screened, significantly increasing the chance of identifying the best colonies.

Using fluorescence labels, ClonePixFL can categorise the cells and pick the superset of highest expressing colonies for subsequent downstream tissue culture.

Picking a smaller number of colonies - those which are the most productive - saves costs and shortens the development timeline. Request a free brochure from Genetix ...

Ian Taylor, business manager at Genetix, commented: "Through an early adoption programme we have already secured commitment for the first orders and have been very encouraged by the early interest shown from customers who expect that this technology will deliver them a competitive edge.".

Genetix: contact details and other news
Email this article to a colleague
Register for the free Laboratorytalk email newsletter
Laboratorytalk Home Page

Search the Pro-Talk network of sites

Visit the Chemometec web site